Brief: Silo Pharma And Resyca BV Partner On Device And Cmc Development For Intranasal Ptsd Drug Spc-15
18/07/2024 13:28
July 18 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA AND RESYCA BV PARTNER ON DEVICE AND CMC
DEVELOPMENT
FOR INTRANASAL PTSD DRUG SPC-15
Source text for Eikon: ID:nGNX6vqzGq
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement